Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.68M Sell
51,040
-232
-0.5% -$12.3K 1.03% 22
2026
Q1
$2.83M Sell
51,272
-6,776
-12% -$367K 1.25% 13
2025
Q4
$2.85M Sell
58,048
-1,172
-2% -$54.7K 1.3% 16
2025
Q3
$2.56M Buy
59,220
+1,774
+3% +$69.3K 1.16% 20
2025
Q2
$2.21M Sell
57,446
-3,298
-5% -$126K 1.06% 29
2025
Q1
$2.35M Buy
60,744
+28,328
+87% +$1.04M 1.18% 22
2024
Q4
$1.1M Sell
32,416
-17,138
-35% -$617K 0.52% 40
2024
Q3
$2.03M Buy
49,554
+1,790
+4% +$73.2K 0.91% 40
2024
Q2
$1.84M Buy
47,764
+4,581
+11% +$193K 0.97% 33
2024
Q1
$1.85M Buy
43,183
+12,088
+39% +$498K 0.95% 28
2023
Q4
$1.15M Buy
+31,095
New +$1.12M 0.75% 31

Other funds holding GSK

Optimist Retirement Group's GSK Position: Q2 2026 in Review

Optimist Retirement Group reduced its GSK (GSK) stake by 0.45% in Q2 2026, selling an estimated $12.3K and leaving 51,040 shares worth $2.68M. The position accounts for 1.03% of the portfolio, ranked #22.

Optimist Retirement Group first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.85M in Q4 2025. 754 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Optimist Retirement Group held 51,040 shares of GSK worth $2.68M as of Q2 2026.
  • Optimist Retirement Group sold 232 GSK shares in Q2 2026, an estimated $12.3K.
  • GSK made up 1.03% of Optimist Retirement Group's portfolio in Q2 2026, its #22 holding.
  • Optimist Retirement Group first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • Optimist Retirement Group's GSK position peaked at $2.85M in Q4 2025.
  • 754 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Optimist Retirement Group's 13F filing for Q2 2026, filed 10 Aug 2026.